Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping

Journal of Cardiac Surgery

Volumn 23, Issue 1, 2008, Pages 44-48

  Katircioglu, S Fehmi ^a   Seren, Mustafa ^a   Parlar, A Ihsan ^a   Turan, Nilufer N ^b   Manavbasi, Yasemin ^b   Aydog, Gulden ^a   Cicekcioglu, Ferit ^a   Tutun, Ufuk ^a   Ulus, A Tulga ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOSIMENDAN; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOADING DRUG DOSE; LUMBAR SPINAL CORD; MEAN ARTERIAL PRESSURE; MICROSCOPY; NEUROPROTECTION; NONHUMAN; RABBIT; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA;

ANIMALS; AORTA; CONSTRICTION; DISEASE MODELS, ANIMAL; HYDRAZONES; MALONDIALDEHYDE; MODELS, CARDIOVASCULAR; PEROXIDASE; PYRIDAZINES; RABBITS; RANDOM ALLOCATION; REPERFUSION INJURY; RESEARCH DESIGN; SINGLE-BLIND METHOD; SPINAL CORD ISCHEMIA; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 39649084228     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2007.00486.x     Document Type: Article

References (30)

1. Svensson LG, Crawford ES, Hess KR, et al : Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993 17 : 357.
2. de Haan P, Kalkman CJ, Jacobs MJ : Pharmacologic neuroprotection in experimental spinal cord ischemia: A systematic review. J Neurosurg Anesthesiol 2001 13 : 3 12.
3. Du Toit EF, Muller CA, McCarthy J, et al : Levosimendan: Effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 1999 290 : 505 514.
4. Kersten JR, Montgomery MW, Pagel PS, et al : Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000 90 : 5 11.
5. Katircioglu SF, Ulus AT, Gokce P, et al : Iloprost protects the spinal cord during aortic cross-clamping in a canine model. J Cardiovasc Surg (Torino) 2000 41 : 89 93.
6. Usul H, Cakir E, Cobanoglu U, et al : The effects of Tyrphostine Ag 556 on experimental spinal cord ischemia reperfusion injury. Surg Neurol 2004 61 : 45 54.
7. Taoka Y, Okajima K, Murakami K, et al : Role of neutrophil elastase in compression-induced spinal cord injury in rats. Brain research 1998 799 : 264 269.
8. Choi DW : Glutamate neurotoxicity and diseases of the nervous system. Neuron 1998 1 : 623 634.
9. Ulus AT, Saritas A, Yamak B, et al : ATP-MgCl2 utilization for spinal cord protection during experimental thoracic aortic occlusion. J Cardiovasc Surg (Torino) 1999 40 : 495 499.
10. Wei EP, Kontos HA : Oxygen radicals in cerebral ischemia. Physiologist 1987 30 : 122 128.
11. Nayler WJ, Poole-Wilson PA, Williams A : Hypoxia and calcium. J Mol Cell Cardiol 1979 11 : 683 706.
12. Kusuoka H, Porterfield JK, Weisman HF, et al : Pathophysiology and pathogenesis of the stunned myocardium. J Clin Invest 1987 79 : 950 961.
13. Steenbergen C, Murphy E, Levy L, et al : Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat hearts. Circ Res 1987 60 : 700 707.
14. Du Toit EF, Opie LH : Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 1992 70 : 960 967.
15. Jamali IN, Kersten JR, Pagel PS, et al : Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesth Analg 1997 85 : 23 29.
16. Lilleberg J, Sundberg S, Hayha M, et al : Haemodynamic dose efficacy of levosimendan in healthy volunteers. Eur J Clin Pharmacol 1994 47 : 267 274.
17. Harkin CP, Pagel PS, Tessmer JP, et al : Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J Cardiovasc Pharmacol 1995 26 : 179 288.
18. Edes I, Kiss E, Kitada Y, et al : Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 1995 77 : 107 113.
19. Rump AF, Acar D, Klaus W : A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesteraseinhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 1994 112 : 757 62.
20. Goto Y, Katsuya H, Takasago T, et al : Calcium-sensitising drug reduces energy cost for excitation-contraction coupling in the failing heart, but not in the normal heart. Circulation 1996 94 (Suppl 8 I545.
21. Yokoshiki H, Katsube Y, Sunagawa M, et al : Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamidesensitive K channel in rat arterial myocytes. Eur J Pharmacol 1997 333 : 249 259.
22. Yokoshiki H, Katsube Y, Sunagawa M, et al : The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther 1997 283 : 375 383.
23. Gross GJ, Auchampach JA : Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992 70 : 223 233.
24. Yao Z, Gross GJ : Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994 89 : 1769 1775.
25. Auchampach JA, Maruyama M, Cavero I, et al : Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992 86 : 311 319.
26. Grover GJ, Newburger J, Slegh PG : Cardioprotective effects of the potassium channel opener chromakalim: Stereo-selectivity and effect on myocardial adenine nucleotides. J Pharmacol Exp Ther 1991 257 : 156 162.
27. Hosoda H, Sunamori M, Watanabe M, et al : Effects of pinacidil combined with potassium cardioplegia on myocardial viability in hypothermic global ischemia followed by perfusion. J Mol Cell Cardiol 1992 24 (Suppl 1 S76.
28. Jentzer JH, Lejemtel TH, Sonnenblick EH, et al : Beneficial effects of amnirone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 1981 48 : 75 83.
29. Rump A, Acar D, Rosen R, et al : Functional and anti-ischemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmacol Toxicol 1994 74 : 244 248.
30. Rump A, Rosen R, Sigmund B, et al : Beneficial effects of amrinone on the size of acute regional ischemia in isolated rabbit hearts. J Cardiothorac Vasc Anesth 1993 7 : 573 578.